Cardiff Oncology Inc (CRDF) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.96
• Market Cap: $128.66M
• EPS: $-0.79
• 52-Week High: $4.56
• 52-Week Low: $1.48

Market Sentiment

Cardiff Oncology Inc currently has a Bullish sentiment score of 0.43.

About Cardiff Oncology Inc

Cardiff Oncology, Inc. is a clinical-stage biotechnology firm headquartered in San Diego, California, specializing in the development of innovative, targeted therapies for cancer treatment. Utilizing its proprietary technology platform, the company is committed to advancing a robust pipeline of drug candidates aimed at improving patient outcomes across various malignancies. With a focus on addressing unmet medical needs in oncology, Cardiff Oncology is well-positioned to make impactful contri...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cardiff Oncology Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CRDF pay dividends?

Cardiff Oncology Inc (CRDF) does not currently pay a regular dividend.

What is CRDF's market cap?

Cardiff Oncology Inc (CRDF) has a market capitalization of $128.66M with a current stock price of $1.96.